Ahead of OncoGenex Merger, Sonus Adds Caspase Program

Boggs, Jennifer
August 2008
BioWorld Today;8/8/2008, Vol. 19 Issue 154, p1
The article deals with the decision of Sonus Pharmaceuticals Inc. to license an early caspase activator program from Bayer HealthCare LLC. The caspase activator program will become part of the upcoming merger of Sonus with OncoGenex Technologies Inc. The license obtained by Sonus enables it to develop a family of preclinical small-molecule compounds that can induce cell death through the activation of the caspase pathway. It is said that caspases are targeted by tumor cells because the cells have lost the ability to complete the cell death process.


Related Articles

  • Struggling Sonus Building Value, Pipeline via OncoGenex Merger. Boggs, Jennifer // BioWorld Today;5/29/2008, Vol. 19 Issue 104, p1 

    The article reports that Sonus Pharmaceuticals Inc., which has fought to rebuild shareholder value following the failure of lead drug Tocosol Paclitaxel in a pivotal Phase III trial, has acquired OncoGenex Technologies Inc. to bolster its clinical pipeline. Terms of the merger deal call for...

  • Merging with OncoGenex, Sonus Adds Program.  // Bioworld Week;8/11/2008, Vol. 16 Issue 32, p4 

    The article reports that Sonus Pharmaceuticals Inc. will bring an additional program with its upcoming merger with OncoGenex Technologies Inc. Under the terms, Sonus Pharmaceuticals Inc. has agreed to pay a license fee of $450,000 plus undisclosed royalties for rights to develop a family of...

  • Bayer, Compugen deal could be worth $500M. Zanki, Tom // njbiz;8/12/2013, p12 

    The article reveals that Tel Aviv, Israel-based genomic based and diagnostic discovery company Compugen Ltd. is eligible to receive more than 500 million dollars in milestone payments under the oncology collaboration and license agreement with pharmaceutical company Bayer HealthCare.

  • Joining Forces.  // Lighting Design & Application;Jul2012, Vol. 42 Issue 7, p14 

    The article announces the acquisition of Virticus Corp. by LSI Industries Inc. and the licensing agreement between Cooper Lighting and Rambus Inc. for the use of the latter's patented lighting innovations.

  • IN BRIEF.  // Imaging & Machine Vision Europe;Apr/May2010, Issue 38, p5 

    The article offers news briefs related to the technological developments in Great Britain including the merger between Andor Technology and Image Acquisition Partner Program, the relocation of the British office of Edmund Optics and the licensing agreement signed by A&B Software to provide Open...

  • 10 Issues that Medical Device Buyers Should Consider. Devgun, Derek; Snelson, Jamie; Weintraub, Daniel // Mergers & Acquisitions: The Dealermaker's Journal;Dec2014, Vol. 49 Issue 12, p38 

    The article offers tips for medical buyers on factors to consider before purchasing research, collaboration and intellectual property licensing agreements to avoid post-cloning issues.

  • Proactive IP Assessment: Work Now to Ensure That All of Your Key Assets Are Protected.  // Orange County Business Journal;4/8/2002, Vol. 25 Issue 14, p27 

    Offers tips on hiring, licensing and development practices for a successful acquisition. Decline in funding and acquisition opportunities; Proposals for companies to conduct a due diligence audit of assets; Processes involved in a due diligence audit.

  • Schiff Nutrition to be sold to bayer for $1.2 billion.  // Enterprise/Salt Lake City;11/5/2012, Vol. 42 Issue 14, p1 

    The article reports on the decision by German drug manufacturer Bayer HealthCare LLC to acquire Salt Lake City, Utah-based Schiff Nutrition International Inc.

  • Bayer AG on Buying Spree Under CEO Marijn Dekkers. FLYNN, MARY KATHLEEN // Mergers & Acquisitions: The Dealermaker's Journal;Dec2012, Vol. 47 Issue 12, p15 

    The article reports on several acquisitions made by Bayer HealthCare LLC including its acquisitions of Schiff Nutrition International Inc., MegaRed and Move Free.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics